BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Birungi FM, Graham S, Uwimana J, van Wyk B. Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study. Tuberc Res Treat 2018;2018:8690714. [PMID: 29854455 DOI: 10.1155/2018/8690714] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Hunter OF, Kyesi F, Ahluwalia AK, Daffé ZN, Munseri P, von Reyn CF, Adams LV. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania. BMC Infect Dis 2020;20:738. [PMID: 33028260 DOI: 10.1186/s12879-020-05471-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Nabity SA, Gunde LJ, Surie D, Shiraishi RW, Kirking HL, Maida A, Auld AF, Odo M, Jahn A, Nyirenda RK, Oeltmann JE. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017). PLoS One 2021;16:e0248115. [PMID: 33793577 DOI: 10.1371/journal.pone.0248115] [Reference Citation Analysis]
3 Busari AA, Oshikoya KA, Adejumo IA, Olanrewaju OA, Usman SO, Badru WA, Oreagba IA, Olayemi SO. Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria. Pan Afr Med J 2021;39:123. [PMID: 34527139 DOI: 10.11604/pamj.2021.39.123.28095] [Reference Citation Analysis]